- Filed
- Dec 18, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Dec 4, 2023 | 24.55M sh |
| Shares Diluted | Q3 2024 · Oct 31, 2023 | 24.26M sh |
| Shares Diluted | Q3 2024 · Oct 31, 2023 | 24.2M sh |
| Shares Diluted restated | Q3 2024 · Oct 31, 2022 | 23.91M sh |
| Shares Diluted restated | Q3 2024 · Oct 31, 2022 | 24.17M sh |
| Stock Repurchased | Q3 2024 · Oct 31, 2023 | $0 |
| Stock Repurchased | Q3 2024 · Oct 31, 2022 | $71.7M |
| Capex | Q3 2024 · Oct 31, 2023 | $40.24M |
| Capex | Q3 2024 · Oct 31, 2022 | $50.21M |
| Operating Cash Flow | Q3 2024 · Oct 31, 2023 | $253K |
| Operating Cash Flow | Q3 2024 · Oct 31, 2022 | $72.53M |
| Long Term Debt | Q3 2024 · Oct 31, 2023 | $673.47M |
| Long Term Debt | Q3 2024 · Jan 31, 2023 | $636.08M |
| Short Term Debt | Q3 2024 · Oct 31, 2023 | $7.93M |
| Short Term Debt | Q3 2024 · Jan 31, 2023 | $937K |
| Cash And Equivalents | Q3 2024 · Oct 31, 2023 | $5.56M |
| Cash And Equivalents | Q3 2024 · Jan 31, 2023 | $19.53M |
| Stockholders Equity | Q3 2024 · Oct 31, 2023 | $390.57M |
| Stockholders Equity | Q3 2024 · Jul 31, 2023 | $439.32M |
| Stockholders Equity | Q3 2024 · Apr 30, 2023 | $469.51M |
| Stockholders Equity | Q3 2024 · Jan 31, 2023 | $502.41M |
| Stockholders Equity | Q3 2024 · Oct 31, 2022 | $543.11M |
| Stockholders Equity | Q3 2024 · Jul 31, 2022 | $559.88M |
| Stockholders Equity | Q3 2024 · Apr 30, 2022 | $554.39M |
| Stockholders Equity | Q3 2024 · Jan 31, 2022 | $614.82M |
| Current Liabilities | Q3 2024 · Oct 31, 2023 | $239.27M |
| Current Liabilities | Q3 2024 · Jan 31, 2023 | $222.36M |
| Total Liabilities | Q3 2024 · Oct 31, 2023 | $1.34B |
| Total Liabilities | Q3 2024 · Jan 31, 2023 | $1.21B |
| Current Assets | Q3 2024 · Oct 31, 2023 | $808.2M |
| Current Assets | Q3 2024 · Jan 31, 2023 | $831.1M |
| Total Assets | Q3 2024 · Oct 31, 2023 | $1.73B |
| Total Assets | Q3 2024 · Jan 31, 2023 | $1.72B |
| Total Assets | Q3 2024 · Oct 31, 2022 | $1.74B |
| Eps Diluted | Q3 2024 · Oct 31, 2023 | −$2.11 |
| Eps Diluted | Q3 2024 · Oct 31, 2023 | −$4.97 |
| Eps Diluted | Q3 2024 · Oct 31, 2022 | −$1.04 |
| Eps Diluted | Q3 2024 · Oct 31, 2022 | −$0.68 |
| Eps Basic | Q3 2024 · Oct 31, 2023 | −$2.11 |
| Eps Basic | Q3 2024 · Oct 31, 2023 | −$4.97 |
| Eps Basic | Q3 2024 · Oct 31, 2022 | −$1.04 |
| Eps Basic | Q3 2024 · Oct 31, 2022 | −$0.68 |
| Sga Expense | Q3 2024 · Oct 31, 2023 | $131.03M |
| Sga Expense | Q3 2024 · Oct 31, 2023 | $395.24M |
| Sga Expense | Q3 2024 · Oct 31, 2022 | $126.24M |
| Sga Expense | Q3 2024 · Oct 31, 2022 | $389.17M |
| Net Income | Q3 2024 · Oct 31, 2023 | −$51.3M |
| Net Income | Q3 2024 · Oct 31, 2023 | −$120.19M |
| Net Income | Q3 2024 · Jul 31, 2023 | −$33.52M |
| Net Income | Q3 2024 · Apr 30, 2023 | −$35.38M |
| Net Income | Q3 2024 · Oct 31, 2022 | −$24.84M |
| Net Income | Q3 2024 · Oct 31, 2022 | −$16.49M |
| Net Income | Q3 2024 · Jul 31, 2022 | $2.13M |
| Net Income | Q3 2024 · Apr 30, 2022 | $6.22M |
| Operating Income | Q3 2024 · Oct 31, 2023 | −$38.46M |
| Operating Income | Q3 2024 · Oct 31, 2023 | −$74.52M |
| Operating Income | Q3 2024 · Oct 31, 2022 | −$18M |
| Operating Income | Q3 2024 · Oct 31, 2022 | $3.96M |
| Cost Of Revenue | Q3 2024 · Oct 31, 2023 | $146.36M |
| Cost Of Revenue | Q3 2024 · Oct 31, 2023 | $448.28M |
| Cost Of Revenue | Q3 2024 · Oct 31, 2022 | $169.84M |
| Cost Of Revenue | Q3 2024 · Oct 31, 2022 | $530.94M |
| Revenue | Q3 2024 · Oct 31, 2023 | $218.45M |
| Revenue | Q3 2024 · Oct 31, 2023 | $684.64M |
| Revenue | Q3 2024 · Oct 31, 2022 | $254.36M |
| Revenue | Q3 2024 · Oct 31, 2022 | $806.13M |